As expected, RNF43 and ZNRF3 mutations tend to be mutually exclusive with APC and β-catenin mutations in those tumor types [38,43], reflecting their shared consequences in activating the Wnt/β-catenin signaling pathway. The gene discussed is RNF43; the disease is neoplasm.